Ampe investors have opportunity to lead ampio pharmaceuticals, inc. securities fraud lawsuit

Los angeles , oct. 6, 2022 /prnewswire/ -- the law offices of frank r. cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against ampio pharmaceuticals, inc. ("ampio" or the "company") (nyse: ampe).

AMPE Ratings Summary

AMPE Quant Ranking